Advanced search
Publication Cover
Autoimmunity Volume 49, 2016 - Issue 7
Submit an article Journal homepage
622
Views
63
CrossRef citations to date
0
Altmetric
Research Article

Effect of therapeutic plasma exchange on immunoglobulins in myasthenia gravis

Jeffrey T. GuptillDivision of Neuromuscular Disease, Department of Neurology, Duke University Medical Center, Durham, NC, USA, Correspondence[email protected]
,
Vern C. JuelDivision of Neuromuscular Disease, Department of Neurology, Duke University Medical Center, Durham, NC, USA,
,
Janice M. MasseyDivision of Neuromuscular Disease, Department of Neurology, Duke University Medical Center, Durham, NC, USA,
,
Amanda C. AndersonDivision of Neuromuscular Disease, Department of Neurology, Duke University Medical Center, Durham, NC, USA,
,
Manisha ChopraNeuromuscular Disorders Section, Department of Neurology, The University of North Carolina, Chapel Hill, NC, USA,
,
John S. YiDivision of Surgical Sciences, Department of Surgery, Duke University Medical Center, Durham, NC, USA,
,
Ehsanollah EsfandiariTakeda TDC Europe, London, UK,
,
Tim BuchananUCB Biosciences, Slough, UK, and
,
Bryan SmithUCB Biosciences, Slough, UK, and
,
Paul AtherfoldUCB Biosciences, Slough, UK, and
,
Emma JonesVeramed Limited, West London, UK
&
James F. Howard JrNeuromuscular Disorders Section, Department of Neurology, The University of North Carolina, Chapel Hill, NC, USA,
show all
Pages 472-479 | Received 06 Apr 2016, Accepted 10 Jul 2016, Published online: 11 Aug 2016

References

  • Conti-Fine, B. M., M. Milani, and H. J. Kaminski. 2006. Myasthenia gravis: past, present, and future. J. Clin. Invest. 116: 2843–2854
  • Sanders, D. B., and J. T. Guptill. 2014. Myasthenia gravis and Lambert-Eaton myasthenic syndrome. Continuum. (Minneap. Minn.). 20: 1413–1425
  • Lagoumintzis, G., P. Zisimopoulou, G. Kordas, et al. 2010. Recent approaches to the development of antigen-specific immunotherapies for myasthenia gravis. [Review]. Autoimmunity 43: 436–445
  • Juel, V. C., and J. M. Massey. 2005. Autoimmune myasthenia gravis: recommendations for treatment and immunologic modulation. Curr. Treat. Options Neurol. 7: 3–14
  • Dau, P. C. 1995. Immunologic rebound. J. Clin. Apher. 10: 210–217
  • Derksen, R. H., H. J. Schuurman, F. H. Gmelig Meyling, et al. 1984. Rebound and overshoot after plasma exchange in humans. J. Lab. Clin. Med. 104: 35–43
  • Dau, P. C. 1996. The fundamental basis for therapeutic plasmapheresis in autoimmune diseases. Transfus. Sci. 17: 235–244
  • Burns, T. M., M. Conaway, D. B. Sanders, MG Composite and M-QL15 Study Group. 2010. The MG composite: a valid and reliable outcome measure for myasthenia gravis. Neurology 74: 1434–1440
  • Sanders, D. B., B. Tucker-Lipscomb, and J. M. Massey. 2003. A simple manual muscle test for myasthenia gravis: validation and comparison with the QMG score. Ann. N.Y. Acad. Sci. 998: 440–444
  • Barth, D., M. Nabavi Nouri, E. Ng, et al. 2011. Comparison of IVIg and PLEX in patients with myasthenia gravis. Neurology 76: 2017–2023
  • Jaretzki A. III, R. J. Barohn, R. M. Ernstoff, et al. 2000. Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology 55: 16–23
  • Volkin, R. L., T. W. Starz, A. Winkelstein, et al. 1982. Changes in coagulation factors, complement, immunoglobulins, and immune complex concentrations with plasma exchange. Transfusion 22: 54–58
  • Reverberi, R., and L. Reverberi. 2007. Removal kinetics of therapeutic apheresis. Blood Transfus. 5: 164–174
  • Dau, P., J. Lindstrom, C. Cassel, and E. Clark. 1978. Plasmapheresis in myasthenia gravis and polymyositis. In Plasmapheresis and the immunobiology of myasthenia gravis. P. Dau, ed. Houghton Mifflin Professional Publishers, Boston, MA. p. 229–241
  • Keesey, J. 1978. Indications for thymectomy in myasthenia gravis. In Plasmapheresis and the immunobiology of myasthenia gravis. P. Dau, ed. Houghton Mifflin Professional Publishers, Boston, MA. p. 124–134
  • Fudenberg, H. H. 1965. The immune globulins. Annu. Rev. Microbiol. 19: 301–338
  • Kaplan, A. A. 2008. Therapeutic plasma exchange: core curriculum 2008. Am. J. Kidney Dis. 52: 1180–1196
  • Rodgaard, A., F. C. Nielsen, R. Djurup, et al. 1987. Acetylcholine receptor antibody in myasthenia gravis: predominance of IgG subclasses 1 and 3. Clin. Exp. Immunol. 67: 82–88
  • Tackenberg, B., J. Kruth, J. E. Bartholomaeus, et al. 2007. Clonal expansions of CD4+ B helper T cells in autoimmune myasthenia gravis. Eur. J. Immunol. 37: 849–863
  • Kornfeld, P., E. P. Ambinder, T. Mittag, et al. 1981. Plasmapheresis in refractory generalized myasthenia gravis. Arch. Neurol. 38: 478–481
  • Advisory Committee on Immunization, PC Centers for Disease and Prevention. 2011. Immunization of health-care personnel: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. Recomm. Rep. 60: 1–45

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.